Matches in SemOpenAlex for { <https://semopenalex.org/work/W4293223872> ?p ?o ?g. }
- W4293223872 endingPage "494" @default.
- W4293223872 startingPage "471" @default.
- W4293223872 abstract "Immunogenicity has imposed a challenge to efficacy and safety evaluation of adeno-associated virus (AAV) vector-based gene therapies. Mild to severe adverse events observed in clinical development have been implicated with host immune responses against AAV gene therapies, resulting in comprehensive evaluation of immunogenicity during nonclinical and clinical studies mandated by health authorities. Immunogenicity of AAV gene therapies is complex due to the number of risk factors associated with product components and pre-existing immunity in human subjects. Different clinical mitigation strategies have been employed to alleviate treatment-induced or -boosted immunogenicity in order to achieve desired efficacy, reduce toxicity, or treat more patients who are seropositive to AAV vectors. In this review, the immunogenicity risk assessment, manifestation of immunogenicity and its impact in nonclinical and clinical studies, and various clinical mitigation strategies are summarized. Last, we present bioanalytical strategies, methodologies, and assay validation applied to appropriately monitor immunogenicity in AAV gene therapy-treated subjects." @default.
- W4293223872 created "2022-08-27" @default.
- W4293223872 creator A5002188070 @default.
- W4293223872 creator A5005182956 @default.
- W4293223872 creator A5006042186 @default.
- W4293223872 creator A5015410009 @default.
- W4293223872 creator A5021424606 @default.
- W4293223872 creator A5023507578 @default.
- W4293223872 creator A5025298275 @default.
- W4293223872 creator A5026216217 @default.
- W4293223872 creator A5032351782 @default.
- W4293223872 creator A5041895745 @default.
- W4293223872 creator A5042823676 @default.
- W4293223872 creator A5044087072 @default.
- W4293223872 creator A5044158194 @default.
- W4293223872 creator A5052083635 @default.
- W4293223872 creator A5067870222 @default.
- W4293223872 creator A5072456835 @default.
- W4293223872 creator A5078752920 @default.
- W4293223872 creator A5085809373 @default.
- W4293223872 creator A5090670617 @default.
- W4293223872 date "2022-09-01" @default.
- W4293223872 modified "2023-10-16" @default.
- W4293223872 title "Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper" @default.
- W4293223872 cites W1487084354 @default.
- W4293223872 cites W1495880776 @default.
- W4293223872 cites W1562298285 @default.
- W4293223872 cites W1908373360 @default.
- W4293223872 cites W191186380 @default.
- W4293223872 cites W1967938540 @default.
- W4293223872 cites W1969271703 @default.
- W4293223872 cites W1971284136 @default.
- W4293223872 cites W1972852573 @default.
- W4293223872 cites W1976329054 @default.
- W4293223872 cites W1981298448 @default.
- W4293223872 cites W1984122872 @default.
- W4293223872 cites W1987114379 @default.
- W4293223872 cites W1990441318 @default.
- W4293223872 cites W1995250629 @default.
- W4293223872 cites W1997567318 @default.
- W4293223872 cites W1999760686 @default.
- W4293223872 cites W2000272681 @default.
- W4293223872 cites W2002368085 @default.
- W4293223872 cites W2004983645 @default.
- W4293223872 cites W2007261697 @default.
- W4293223872 cites W2008254103 @default.
- W4293223872 cites W2009247311 @default.
- W4293223872 cites W2026894132 @default.
- W4293223872 cites W2027049071 @default.
- W4293223872 cites W2030914433 @default.
- W4293223872 cites W2032583774 @default.
- W4293223872 cites W2033505817 @default.
- W4293223872 cites W2034661134 @default.
- W4293223872 cites W2043149070 @default.
- W4293223872 cites W2044395911 @default.
- W4293223872 cites W2045292147 @default.
- W4293223872 cites W2045817726 @default.
- W4293223872 cites W2047667011 @default.
- W4293223872 cites W2053218323 @default.
- W4293223872 cites W2053820810 @default.
- W4293223872 cites W2055456476 @default.
- W4293223872 cites W2055737319 @default.
- W4293223872 cites W2056144642 @default.
- W4293223872 cites W2056289301 @default.
- W4293223872 cites W2056721231 @default.
- W4293223872 cites W2057134222 @default.
- W4293223872 cites W2057767029 @default.
- W4293223872 cites W2063518906 @default.
- W4293223872 cites W2064420935 @default.
- W4293223872 cites W2064736759 @default.
- W4293223872 cites W2067074806 @default.
- W4293223872 cites W2067204822 @default.
- W4293223872 cites W2070868140 @default.
- W4293223872 cites W2073545118 @default.
- W4293223872 cites W2073739917 @default.
- W4293223872 cites W2074604840 @default.
- W4293223872 cites W2075227451 @default.
- W4293223872 cites W2075955241 @default.
- W4293223872 cites W2076344904 @default.
- W4293223872 cites W2081807684 @default.
- W4293223872 cites W2082025265 @default.
- W4293223872 cites W2086174979 @default.
- W4293223872 cites W2087513462 @default.
- W4293223872 cites W2088410491 @default.
- W4293223872 cites W2091718181 @default.
- W4293223872 cites W2095942414 @default.
- W4293223872 cites W2097180939 @default.
- W4293223872 cites W2100119864 @default.
- W4293223872 cites W2105176806 @default.
- W4293223872 cites W2110223801 @default.
- W4293223872 cites W2112570403 @default.
- W4293223872 cites W2113089955 @default.
- W4293223872 cites W2116885047 @default.
- W4293223872 cites W2118510193 @default.
- W4293223872 cites W2120423141 @default.
- W4293223872 cites W2121997646 @default.
- W4293223872 cites W2122236774 @default.
- W4293223872 cites W2122304523 @default.